Amy Jones
Researcher
University of Arkansas for Medical Sciences
faculty
Research Areas
Links
Is this your profile? Verify and claim your profile
Biography and Research Information
OverviewAI-generated summary
Amy Jones's research focuses on the treatment of cervical intraepithelial neoplasia (CIN) and related human papillomavirus (HPV) infections. She has investigated the efficacy of a peptide-based therapeutic vaccine, PepCan, in combination with a Candida adjuvant, in clinical trials. Her work has explored the impact of these interventions on CIN2/3 lesions. Jones also has an interest in medical education, as indicated by her publication assessing changes in training for palliative medicine specialty. Her scholarship metrics include an h-index of 6, with 28 total publications and 195 citations. She has collaborated with researchers Charles M. Quick, David W. Ussery, Michael Scott Robeson, and William W. Greenfield at the University of Arkansas for Medical Sciences, with whom she shares multiple publications.
Metrics
- h-index: 6
- Publications: 28
- Citations: 195
Selected Publications
- A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or <i>Candida</i> (2025) DOI
- A peptide-based human papillomavirus therapeutic vaccine, PepCan, or <i>Candida</i> adjuvant alone in treatment of cervical intraepithelial neoplasia 2/3 (CIN2/3). (2023) DOI
Collaborators
Researchers in the database who share publications
Similar Researchers
Based on overlapping research topics